BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 5684262)

  • 1. A comparative behavioral study of ditran and LSD in mice, rats, and dogs.
    Cohen M; Wakeley H
    Arch Int Pharmacodyn Ther; 1968 Jun; 173(2):316-26. PubMed ID: 5684262
    [No Abstract]   [Full Text] [Related]  

  • 2. Some observations on the behavioural effects of hallucinogenic drugs on rats: potentiation by two drugs affecting monoamine metabolism.
    Tonge SR; Leonard BE
    Arch Int Pharmacodyn Ther; 1972 Jan; 195(1):168-76. PubMed ID: 5010826
    [No Abstract]   [Full Text] [Related]  

  • 3. Alteration of some patterns of spontaneous behavior in rats after LSD.
    Kabes J; Fink Z
    Act Nerv Super (Praha); 1971; 13(2):99-100. PubMed ID: 5145604
    [No Abstract]   [Full Text] [Related]  

  • 4. An investigation on the behavioral and hypothermic effects of yohimbine: interaction with drugs affecting central and peripheral monoamines.
    Papeschi R
    Arch Int Pharmacodyn Ther; 1974 Mar; 208(1):61-80. PubMed ID: 4276928
    [No Abstract]   [Full Text] [Related]  

  • 5. Reduction of conditioned suppression: actions of morphine compared with those of amphetamine, pentobarbital, nalorphine, cocaine, LSD-25 and chlorpromazine.
    Hill HE; Bell EC; Wikler A
    Arch Int Pharmacodyn Ther; 1967 Jan; 165(1):212-26. PubMed ID: 6030238
    [No Abstract]   [Full Text] [Related]  

  • 6. The influence of haloperidol and propranolol on behavior and biochemical changes in the brain of mice treated with LSD.
    Kocur J; Jurkowski A; Kedziora J
    Pol J Pharmacol Pharm; 1977; 29(3):281-8. PubMed ID: 196269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pharmacological analysis of processes underlying differential responding: a review and further experiments with scopolamine, amphetamine, lysergic acid diethylamide (LSD-25), chlordiazepoxide, physostigmine, and chlorpromazine.
    Frontali M; Amorico L; De Acetis L; Bignami G
    Behav Biol; 1976 Sep; 18(1):1-74. PubMed ID: 791242
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effects of D-lysergic acid diethylamide (LSD-25) and 2-bromo-D-lysergic acid diethylamide (BOL-148) on sleeping behavior in rats].
    Loew DM; Depoortere H; Vigouret JM
    Naunyn Schmiedebergs Arch Pharmakol; 1970; 266(4):394-5. PubMed ID: 4326420
    [No Abstract]   [Full Text] [Related]  

  • 9. Suppression of lysergic acid diethylamide (LSD) effects in pregnant rats.
    Bergen JR
    Res Commun Chem Pathol Pharmacol; 1972 Mar; 3(2):313-9. PubMed ID: 4679854
    [No Abstract]   [Full Text] [Related]  

  • 10. [Behavioral and neurophysiological study of the effect of LSD 25 in the monkey].
    Borenstein P; Chatelier G; Cujo P; Gekière F
    Sem Hop; 1969 Apr; 45(19):1258-70. PubMed ID: 4306998
    [No Abstract]   [Full Text] [Related]  

  • 11. Behavioral tolerance to the effects of LSD in the rat.
    Commissaris RL; Lyness WH; Cordon JJ; Moore KE; Rech RH
    Subst Alcohol Actions Misuse; 1980; 1(2):203-7. PubMed ID: 7302781
    [No Abstract]   [Full Text] [Related]  

  • 12. Hyperthermic effects of D-lysergic acid diethylamide (LSD) and its derivatives in rabbits and rats.
    Hashimoto H; Hayashi M; Nakahara Y; Niwaguchi T; Ishii H
    Arch Int Pharmacodyn Ther; 1977 Aug; 228(2):314-21. PubMed ID: 303504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between alteration of the cholinergic system and behavioral effects of LSD in rats.
    Kabes J; Fink Z
    Act Nerv Super (Praha); 1970; 12(3):261. PubMed ID: 5457449
    [No Abstract]   [Full Text] [Related]  

  • 14. Behavioural actions of some substituted amphetamines.
    Buxton DA
    Prog Brain Res; 1972; 36():171-81. PubMed ID: 4644027
    [No Abstract]   [Full Text] [Related]  

  • 15. [A neurophysiological study on the central action of psychotomimetics (LSD 25, DOM and ketamine) (author's transl)].
    Otaka T
    Seishin Shinkeigaku Zasshi; 1974; 76(2):103-28. PubMed ID: 4472773
    [No Abstract]   [Full Text] [Related]  

  • 16. Sex differences in the effects of N,N-diethyllysergamide (LSD) on behavioural activity and prepulse inhibition.
    Pálenícek T; Hlinák Z; Bubeníková-Valesová V; Novák T; Horácek J
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 May; 34(4):588-96. PubMed ID: 20156516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An improved method for detecting drug effects in the open field.
    Leyland CM; Gwyther RJ; Rylands JM
    Psychopharmacology (Berl); 1979 May; 63(1):33-7. PubMed ID: 112619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cumulative alterations in rat behavior during continuous administration of LSD or mescaline: absence of tolerance?
    Ellison G; Ring M; Ross D; Axelrood B
    Biol Psychiatry; 1980 Feb; 15(1):95-102. PubMed ID: 7357060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioral evidence for the stimulation of CNS serotonin receptors by high doses of LSD.
    Trulson ME; Ross CA; Jacobs BL
    Psychopharmacol Commun; 1976; 2(2):149-64. PubMed ID: 136010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of the stimulus effects of morphine and lysergic acid diethylamide (LSD).
    Hirschhorn ID; Rosecrans JA
    Pharmacol Biochem Behav; 1974 May; 2(3):361-6. PubMed ID: 4837907
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.